Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

Accrued Expenses

6 Months Ended

Jun. 30, 2016

Payables and Accruals [Abstract]

Accrued Expenses

7.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

		June 30, 2016				December 31, 2015

Accrued clinical operations and trials costs		$	1,302,309			$	365,188
Accrued product development costs			405,578				152,018
Accrued audit fees			1,500				16,500
Accrued payroll and related			109,442				-
Accrued other			96,222				28,573
Total		$	1,915,051			$	562,279